Is being a Regulatory Affairs Manager
at risk from AI?

Not in the foreseeable future, but the role will transform significantly. AI is already automating routine document preparation, compliance tracking, and initial regulatory research—tasks that currently consume 30-40% of a typical manager's time. However, the core value of regulatory affairs lies in strategic judgment, relationship management with agencies, and navigating ambiguous or unprecedented situations. Regulators require human accountability, and the high-stakes nature of drug and device approvals means organizations will continue to need experienced professionals who can interpret guidance, negotiate with agencies, and make risk-informed decisions. The managers who thrive will be those who use AI to handle the mechanical work while focusing their energy on strategy, relationships, and cross-functional leadership.

Expect incremental automation over the next 3-5 years rather than sudden displacement. We're already seeing AI tools that can draft sections of regulatory submissions, monitor global regulatory databases, and flag compliance gaps. By 2027-2028, most organizations will use AI assistants for document assembly and routine tracking, reducing the need for junior-level staff who primarily handle these tasks. However, senior regulatory affairs managers—those who own strategy, maintain agency relationships, and provide expert interpretation—will remain in demand. The bigger shift will be in team composition: fewer junior associates, more strategic advisors, and a higher bar for what 'regulatory expertise' means.

Yes, but focus on becoming an expert user and interpreter rather than a builder. Familiarize yourself with regulatory intelligence platforms that use AI to monitor global changes (tools like Cortellis Regulatory Intelligence are adding AI features), document automation systems, and compliance management software with predictive analytics. More importantly, develop the skill of critically evaluating AI-generated outputs—knowing when the AI has missed nuance, misinterpreted guidance, or failed to account for organizational context. The most valuable regulatory professionals in 2028 will be those who can leverage AI to work 3-5x faster while applying human judgment to the 20% of decisions that truly matter.

Expect a widening gap between strategic and execution-focused roles. Entry-level and mid-level positions that primarily involve document preparation and routine compliance tracking will face downward salary pressure as AI handles more of this work. However, senior regulatory affairs managers with deep agency relationships, strategic expertise, and track records of successful approvals will likely see stable or even increasing compensation—they're becoming scarcer and more valuable. The market is already showing this: organizations are willing to pay premium salaries for regulatory leaders who can navigate complex global strategies, but they're hiring fewer junior staff. If you're early in your career, focus on accelerating toward strategic responsibilities rather than spending years in purely execution-focused roles.

Yes—AI adoption and impact vary significantly by sector. Pharmaceutical regulatory affairs faces moderate AI disruption because drug submissions are highly standardized and data-intensive, making them good targets for automation. Medical device regulatory affairs has more variability in submission types and relies heavily on engineering judgment, providing some insulation. Emerging areas like digital health, AI/ML-enabled devices, and gene therapy offer the most resilience because regulatory frameworks are still evolving and precedent is limited—human expertise is at a premium when the rules themselves are unclear. If you have flexibility, consider specializing in novel modalities or technologies where regulatory pathways are still being established.

Significantly more secure for senior professionals, but the path to senior roles is narrowing. Junior regulatory affairs associates who spend their first 3-5 years primarily preparing documents and tracking submissions are most at risk—AI is targeting exactly these tasks. Senior managers who own regulatory strategy, maintain agency relationships, and provide expert interpretation of ambiguous guidance are well-positioned. The challenge is that organizations may hire fewer junior staff and expect new hires to reach strategic competency faster. If you're junior, focus on getting exposure to agency interactions, strategic decision-making, and cross-functional leadership as quickly as possible rather than becoming excellent at tasks AI will soon handle.

Yes, though less pronounced than in some other professions. Regulatory affairs for major markets (US FDA, EU EMA, Japan PMDA) will see faster AI adoption because these agencies have well-documented processes and large datasets for AI training. Emerging markets with less standardized or more relationship-dependent regulatory systems may see slower automation. However, the global nature of pharmaceutical and device development means most regulatory affairs managers work across multiple jurisdictions. Your resilience depends more on whether you're doing strategic multi-market planning versus single-country execution. Professionals who can navigate the complexity of simultaneous global submissions and understand regional nuances will remain valuable regardless of location.